INH and INH-RPT Treatment for LTBI
Latent Mycobacterium tuberculosis infection is itself, a latent disease requiring chemical prophylaxis to forestall the onset of active tuberculosis. Treatment of latent tuberculosis (TB) infection is a critical for patients with a high risk of developing active TB. This treatment is also considered central to the complete elimination of TB in the US and elsewhere in the world. Patient education on the risks of TB onset and medication discontinuation is important for the therapy’s success. While INH therapy can mitigate the risk of onset of TB diseases in immune-competent individuals by up to 90%, the failure to take Continue reading...